Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
The Annals of Otology, Rhinology, and Laryngology|March 27, 2003
Barotrauma vis-a-vis the "chronic otitis media syndrome": two conditions with middle ear gas deficiency Is secretory otitis media a contraindication to air travel?Jacob Sadé, Amos Ar, Camil FuchsThe Israel Journal of Psychiatry and Related Sciences|December 31, 2009
Effect of the selective norepinephrine reuptake inhibitor reboxetine on cognitive dysfunction in schizophrenia patients: an add-on, double-blind placebo-controlled studyMichael Poyurovsky, Sarit Faragian, Camil Fuchs, et al.The Annals of Otology, Rhinology, and Laryngology|May 7, 2003
Is secretory otitis media a single disease entity?Jacob Sadé, Eyal Russo, Camil Fuchs, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 19, 2009
Obsessive-compulsive symptom dimensions in schizophrenia patients with comorbid obsessive-compulsive disorderSarit Faragian, Artashes Pashinian, Camil Fuchs, et al.Acta Oto-Laryngologica|August 23, 2006
Acute otitis media and mastoid growthJacob Sadé, Eyal Russo, Camil Fuchs, et al.Psychiatry Research|June 6, 2021
Rate of OCD and sub-threshold OCD in bipolar disorder patients with first depressive episodeLeonid Braverman, Camil Fuchs, Abraham Weizman, et al.Biological Psychiatry|February 25, 2006
Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trialMichael Poyurovsky, Artashes Pashinian, Ronit Weizman, et al.Psychiatry Research|March 23, 2012
Age-of-onset of schizophrenic and obsessive-compulsive symptoms in patients with schizo-obsessive disorderSarit Faragian, Camil Fuchs, Artashes Pashinian, et al.Psychopharmacology|December 15, 2012
Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine-betahistine combinationMichael Poyurovsky, Camil Fuchs, Artashez Pashinian, et al.Journal of Clinical Psychopharmacology|June 27, 2003
Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot studyMichael Poyurovsky, Svetlana Epshtein, Camil Fuchs, et al.Pageof 3